E-LIB Suche - Ergebnisse für: Bordi, P.

1

227P Sexual dimorphism in immune profile of early and advan..:

Mazzaschi, G. ; Indries, P. ; Monica, G....
ESMO Open. 9 (2024) - p. 102867 , 2024

Link: https://doi.org/10.1016/..

2

Activity of osimeRTInib in non-small-cell lung Cancer with ..:

Pizzutilo, E.G. ; Agostara, A.G. ; Oresti, S....
ESMO Open. 9 (2024) 6 - p. 103592 , 2024

Link: https://doi.org/10.1016/..

3

EP11.01-01 Final Analysis of First-Line Chemo-Immunotherapy..:

Leonetti, A. ; Perrone, F. ; Puntoni, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S610 , 2023

Link: https://doi.org/10.1016/..

4

5P Blood immune-inflammatory dynamic unveils distinctive ir..:

Mazzaschi, G. ; Barbieri, M. ; Monica, G....
Immuno-Oncology and Technology. 20 (2023) - p. 100476 , 2023

Link: https://doi.org/10.1016/..

5

Resistance to osimertinib in advanced EGFR-mutated NSCLC: a..:

Leonetti, A. ; Verzè, M. ; Minari, R....
British Journal of Cancer. 130 (2023) 1 - p. 135-142 , 2023

Link: https://doi.org/10.1038/..

6

189P The parallel interrogation of tissue and peripheral bl..:

Mazzaschi, G. ; Bocchialini, G. ; Lorusso, B....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S143 , 2023

Link: https://doi.org/10.1016/..

7

NGS Testing on Plasma-based ctDNA Samples at Key Clinical T..:

Verzè, M. ; Minari, R. ; Bordi, P....
The Journal of Liquid Biopsy. 1 (2023) - p. 100061 , 2023

Link: https://doi.org/10.1016/..

8

P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Ra..:

Mazzaschi, G. ; Moron Dalla Tor, L. ; Milanese, G....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S120-S121 , 2022

Link: https://doi.org/10.1016/..

9

EP02.04-001 Alectinib as Neoadjuvant Treatment in Surgicall..:

Leonetti, A. ; Minari, R. ; Boni, L....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S231 , 2022

Link: https://doi.org/10.1016/..

10

238P Exploring blood immune cell dynamics to unravel the im..:

Mazzaschi, G. ; Tamarozzi, P. ; Lorusso, B....
Immuno-Oncology and Technology. 16 (2022) - p. 100227 , 2022

Link: https://doi.org/10.1016/..

11

EP08.01-007 Real-World Outcomes of Patients with Advanced L..:

F. Perrone, A. Leonetti ; Puntoni, M. ; Bordi, P....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S338-S339 , 2022

Link: https://doi.org/10.1016/..

12

Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclos..:

Mazzaschi, G. ; Minari, R. ; Zecca, A....
Lung Cancer. 148 (2020) - p. 1-11 , 2020

Link: https://doi.org/10.1016/..

13

Osimertinib beyond disease progression in T790M EGFR-positi..:

Cortellini, A. ; Leonetti, A. ; Catino, A....
Clinical and Translational Oncology. 22 (2019) 6 - p. 844-851 , 2019

Link: https://doi.org/10.1007/..

14

Real-world outcomes according to treatment strategies in AL..:

Gobbini, E. ; Chiari, R. ; Pizzutillo, P....
Clinical and Translational Oncology. 22 (2019) 3 - p. 294-301 , 2019

Link: https://doi.org/10.1007/..

15

Primary resistance to osimertinib due to SCLC transformatio..:

Minari, R. ; Bordi, P. ; Del Re, M....
Lung Cancer. 115 (2018) - p. 21-27 , 2018

Link: https://doi.org/10.1016/..